Clínica Universidad de Navarra (CUN)

2017

1. * Human Amniotic Mesenchymal Stromal Cells as Favorable Source for Cartilage Repair

   Tissue engineering. Part A, Vol. 23, Núm. 17-18, pp. 901-912

2. 11C-Methionine-PET in multiple myeloma: A combined study from two different institutions

   Theranostics, Vol. 7, Núm. 11, pp. 2956-2964

3. 18F-FDG PET/CT in breast cancer: Evidence-based recommendations in initial staging

   Tumor Biology, Vol. 39, Núm. 10, pp. 1-23

4. 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of malignancy in patients with paraneoplastic neurological syndrome: a systematic review and meta-analysis

   European Journal of Nuclear Medicine and Molecular Imaging, Vol. 44, Núm. 9, pp. 1575-1587

5. 18F-fluoromisonidazole PET and activity of neoadjuvant nintedanib in early HER2-negative breast cancer: A window-of-opportunity randomized trial

   Clinical Cancer Research, Vol. 23, Núm. 6, pp. 1432-1441

6. 3D waterfall plots: A better graphical representation of tumor response in oncology

   Annals of Oncology

7. A Next-Generation Sequencing Strategy for Evaluating the Most Common Genetic Abnormalities in Multiple Myeloma

   Journal of Molecular Diagnostics, Vol. 19, Núm. 1, pp. 99-106

8. A Proposal of the European Association for the Study of Obesity to Improve the ICD-11 Diagnostic Criteria for Obesity Based on the Three Dimensions Etiology, Degree of Adiposity and Health Risk

   Obesity Facts, Vol. 10, Núm. 4, pp. 284-307

9. A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials

   Leukemia, Vol. 31, Núm. 2, pp. 318-324

10. A consensus statement on the gender perspective in lung cancer

    Clinical and Translational Oncology, Vol. 19, Núm. 5, pp. 527-535

11. A cumulative effect involving malfunction of the PTH1R and ATP4A genes explains a familial gastric neuroendocrine tumor with hypothyroidism and arthritis

    Gastric Cancer, Vol. 20, Núm. 6, pp. 998-1003

12. A definition for aggressive disease in patients with HER-2 negative metastatic breast cancer: an expert consensus of the Spanish Society of Medical Oncology (SEOM)

    Clinical and Translational Oncology, Vol. 19, Núm. 5, pp. 616-624

13. A multidisciplinary approach allows identification of a new pathogenic CDH1 germline missense mutation in a hereditary diffuse gastric cancer family

    Digestive and Liver Disease

14. A new case of congenital malabsorptive diarrhea and diabetes secondary to mutant Neurogenin-3

    Pediatrics, Vol. 140, Núm. 2

15. A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients

    Journal of Translational Medicine, Vol. 15, Núm. 1

16. A randomised trial of paclitaxel-eluting balloon after bare metal stent implantation vs. bare metal stent in ST-elevation myocardial infarction (the PEBSI study)

    EuroIntervention, Vol. 12, Núm. 13, pp. 1587-1594

17. A randomized phase II/III study of cabazitaxel versus vinflunine in metastatic or locally advanced transitional cell carcinoma of the urothelium (SECAVIN)

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 28, Núm. 7, pp. 1517-1522

18. A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS)

    Leukemia, Vol. 31, Núm. 1, pp. 107-114

19. A retrospective analysis of 3954 patients in phase 2/3 trials of bortezomib for the treatment of multiple myeloma: towards providing a benchmark for the cardiac safety profile of proteasome inhibition in multiple myeloma

    British Journal of Haematology, Vol. 178, Núm. 4, pp. 547-560

20. A simple algorithm for the identification of clinical COPD phenotypes

    European Respiratory Journal, Vol. 50, Núm. 5